- Home
- HAFN vs HTFL Comparison
HAFN vs HTFL Comparison
Compare HAFN & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HAFN | HTFL |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | HAFN | HTFL |
|---|---|---|
| Price | $6.10 | $28.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $39.20 |
| AVG Volume (30 Days) | ★ 1.3M | 846.7K |
| Earning Date | 02-26-2026 | 03-27-2026 |
| Dividend Yield | ★ 6.50% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $2,221,808,000.00 | $161,881,000.00 |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | $0.30 | $22.27 |
| P/E Ratio | $10.07 | ★ N/A |
| Revenue Growth | N/A | ★ 85.70 |
| 52 Week Low | $3.61 | $25.38 |
| 52 Week High | $6.64 | $41.22 |
Technical Indicators
Market Signals| Indicator | HAFN | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 62.87 | 38.96 |
| Support Level | $5.63 | $30.33 |
| Resistance Level | $6.25 | $32.75 |
| Average True Range (ATR) | 0.13 | 2.12 |
| MACD | 0.05 | -0.61 |
| Stochastic Oscillator | 76.42 | 13.89 |
Price Performance
Historical ComparisonAbout HAFN Hafnia Limited
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.